Conatus Pharmaceuticals (CNAT)

5.24 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/2/18 *Est.)

Latest Headlines

Exclusive: Sanctions-hit Vekselberg repays 1 billion Swiss franc credits to Western banks May 19, 2018 9:54 AM - StreetInsider Form 4 Conatus Pharmaceuticals For: May 04 Filed by: Mento Steven J May 7, 2018 7:47 PM - SEC Filing Form 10-Q Conatus Pharmaceuticals For: Mar 31 May 3, 2018 4:11 PM - SEC Filing Form 8-K Conatus Pharmaceuticals For: May 02 May 2, 2018 4:08 PM - SEC Filing Conatus Pharmaceuticals Reports First Quarter 2018 Financial Results and Program Updates May 2, 2018 4:05 PM - Globe NewsWire Conatus Pharmaceuticals (CNAT) Announces Complete Enrollment in ENCORE-PH Phase 2b Clinical Trial of Emricasan in Patients with NASH Cirrhosis & Severe Portal Hypertension April 30, 2018 7:34 AM - StreetInsider Conatus Announces Completion of Enrollment in ENCORE-PH Phase 2b Clinical Trial of Emricasan in Patients with NASH Cirrhosis and Severe Portal Hypertension April 30, 2018 7:30 AM - Globe NewsWire Form DEF 14A Conatus Pharmaceuticals For: Jun 21 April 27, 2018 4:59 PM - SEC Filing Conatus Pharmaceuticals to Report First Quarter 2018 Financial Results April 25, 2018 4:05 PM - Globe NewsWire Conatus Pharmaceuticals (CNAT) Highlights Publication of Results from both In-Vitro & In-Vivo Studies of IDN-7314 Pan-caspase Inhibitor April 18, 2018 7:33 AM - StreetInsider Conatus Pharmaceuticals’ IDN-7314 Pan-caspase Inhibitor Reduces Hepatic Tissue Factor-Driven Coagulation In Vitro and In Vivo April 18, 2018 7:30 AM - Globe NewsWire Ex-telecom company CEO accused of luring investors with fake contracts April 12, 2018 7:11 PM - StreetInsider Conatus Pharmaceuticals Announces Upcoming Oral Presentation at EASL Annual Meeting April 9, 2018 7:30 AM - Globe NewsWire Pre-Open Movers 04/05: (CHFS) (FNSR) (HRTX) Higher; (CNAT) (CHECK) (CONN) Lower (more...) April 5, 2018 9:17 AM - StreetInsider Conatus Pharmaceuticals (CNAT) PT Lowered to $20 at SunTrust Robinson Humphrey April 5, 2018 1:04 AM - StreetInsider After-Hours Stock Movers 04/04: (FB) (AMD) Higher; (CNAT) (CHEK) (OLLI) Lower (more...) April 4, 2018 5:45 PM - StreetInsider Conatus Pharmaceuticals (CNAT) to Resume Trading at 4:35 pm ET April 4, 2018 4:10 PM - StreetInsider Conatus Pharmaceuticals (CNAT) Phase 2b POLT-HCV-SVR Clinical Trial Doesn't Meet Primary Endpoint April 4, 2018 4:07 PM - StreetInsider Form 8-K Conatus Pharmaceuticals For: Apr 04 April 4, 2018 4:05 PM - SEC Filing Conatus Pharmaceuticals Announces Top-line Results from Phase 2b POLT-HCV-SVR Clinical Trial April 4, 2018 4:05 PM - Globe NewsWire Conatus Pharmaceuticals (CNAT) Halted, News Pending April 4, 2018 4:00 PM - StreetInsider Full Article List